Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
1,000 34 39 34 39 B-lower_bound
cells 40 45 40 45 I-lower_bound
/ 45 46 45 46 I-lower_bound
dL 46 48 46 48 I-lower_bound
( 49 50 49 50 O
1.0 50 53 50 53 O
x 54 55 54 55 O
10e9 56 60 56 60 O
/ 60 61 60 61 O
L 61 62 61 62 O
) 62 63 62 63 O
( 64 65 64 65 O
Growth 65 71 65 71 O
factor 72 78 72 78 O
can 79 82 79 82 O
not 82 85 82 85 O
be 86 88 86 88 O
used 89 93 89 93 O
within 94 100 94 100 O
the 101 104 101 104 O
previous 105 113 105 113 B-upper_bound
7 114 115 114 115 I-upper_bound
days 116 120 116 120 I-upper_bound
) 120 121 120 121 O

Biopsy 0 6 122 128 B-treatment
proven 7 13 129 135 O
plasmacytoma 14 26 136 148 B-cancer
( 27 28 149 150 O
should 28 34 150 156 O
be 35 37 157 159 O
measured 38 46 160 168 O
within 47 53 169 175 O
28 54 56 176 178 B-upper_bound
days 57 61 179 183 I-upper_bound
prior 62 67 184 189 I-upper_bound
to 68 70 190 192 O
initial 71 78 193 200 O
investigational 79 94 201 216 B-treatment
agent 95 100 217 222 I-treatment
dosing 101 107 223 229 O
) 107 108 229 230 O

Confirmed 0 9 231 240 O
evidence 10 18 241 249 O
of 19 21 250 252 O
relapse 22 29 253 260 O
/ 29 30 260 261 O
disease 30 37 261 268 O
progression 38 49 269 280 O
from 50 54 281 285 O
immediately 55 66 286 297 O
prior 67 72 298 303 O
MM 73 75 304 306 B-treatment
therapy 76 83 307 314 I-treatment
or 84 86 315 317 O
refractory 87 97 318 328 O
to 98 100 329 331 O
the 101 104 332 335 O
immediately 105 116 336 347 O
prior 117 122 348 353 B-treatment
treatment 123 132 354 363 I-treatment

Creatinine 0 10 364 374 B-clinical_variable
clearance 11 20 375 384 I-clinical_variable
≥ 21 22 385 386 O
30 23 25 387 389 B-lower_bound
mL 26 28 390 392 I-lower_bound
/ 28 29 392 393 I-lower_bound
min 29 32 393 396 I-lower_bound
( 33 34 397 398 O
Cockcroft 34 43 398 407 B-clinical_variable
- 43 44 407 408 I-clinical_variable
Gault 44 49 408 413 I-clinical_variable
equation 50 58 414 422 I-clinical_variable
) 58 59 422 423 O

Daily 0 5 424 429 O
requirement 6 17 430 441 O
for 18 21 442 445 O
corticosteroids 22 37 446 461 B-treatment
( 38 39 462 463 O
> 39 40 463 464 O
10 40 42 464 466 B-lower_bound
mg 43 45 467 469 I-lower_bound
prednisone 46 56 470 480 B-treatment
QD 57 59 481 483 O
or 60 62 484 486 O
equivalent 63 73 487 497 O
) 73 74 497 498 O

Diagnosed 0 9 499 508 O
or 10 12 509 511 O
treated 13 20 512 519 O
for 21 24 520 523 O
another 25 32 524 531 O
malignancy 33 43 532 542 B-cancer
within 44 50 543 549 O
3 51 52 550 551 B-upper_bound
years 53 58 552 557 I-upper_bound
of 59 61 558 560 O
enrollment 62 72 561 571 O

Diagnosis 0 9 572 581 O
of 10 12 582 584 O
MM 13 15 585 587 B-cancer
and 16 19 588 591 O
documentation 20 33 592 605 O
of 34 36 606 608 O
treatment 37 46 609 618 B-treatment
with 47 51 619 623 I-treatment
an 52 54 624 626 I-treatment
IMiD 55 59 627 631 I-treatment
® 59 60 631 632 O
and 61 64 633 636 O
proteasome 65 75 637 647 B-treatment
inhibitor 76 85 648 657 I-treatment

Females 0 7 658 665 B-gender
of 8 10 666 668 O
childbearing 11 23 669 681 O
potential 24 33 682 691 O
( 34 35 692 693 O
FCBP 35 39 693 697 O
) 39 40 697 698 O

Gastro 0 6 699 705 B-chronic_disease
- 6 7 705 706 I-chronic_disease
intestinal 7 17 706 716 I-chronic_disease
abnormalities 18 31 717 730 I-chronic_disease
, 31 32 730 731 O
including 33 42 732 741 O
bowel 43 48 742 747 B-chronic_disease
obstruction 49 60 748 759 I-chronic_disease

Hemoglobin 0 10 760 770 B-clinical_variable
≥ 11 12 771 772 O
8.0 13 16 773 776 B-lower_bound
g 17 18 777 778 I-lower_bound
/ 18 19 778 779 I-lower_bound
dl 19 21 779 781 I-lower_bound
( 22 23 782 783 O
without 23 30 783 790 O
transfusion 31 42 791 802 B-treatment
within 43 49 803 809 O
the 50 53 810 813 O
previous 54 62 814 822 B-upper_bound
7 63 64 823 824 I-upper_bound
days 65 69 825 829 I-upper_bound
) 69 70 829 830 O

History 0 7 831 838 O
of 8 10 839 841 O
significant 11 22 842 853 O
cardiovascular 23 37 854 868 B-chronic_disease
disease 38 45 869 876 I-chronic_disease
unless 46 52 877 883 O
the 53 56 884 887 O
disease 57 64 888 895 O
is 65 67 896 898 O
well 68 72 899 903 O
- 72 73 903 904 O
controlled 73 83 904 914 O
or 84 86 915 917 O
history 87 94 918 925 O
of 95 97 926 928 O
myocardial 98 108 929 939 B-chronic_disease
infarction 109 119 940 950 I-chronic_disease
in 120 122 951 953 O
the 123 126 954 957 O
past 127 131 958 962 B-upper_bound
6 132 133 963 964 I-upper_bound
months 134 140 965 971 I-upper_bound

In 0 2 972 974 O
the 3 6 975 978 O
expansion 7 16 979 988 O
cohort 17 23 989 995 O
, 23 24 995 996 O
at 25 27 997 999 O
least 28 33 1000 1005 O
10 34 36 1006 1008 B-lower_bound
patients 37 45 1009 1017 O
will 46 50 1018 1022 O
be 51 53 1023 1025 O
required 54 62 1026 1034 O
to 63 65 1035 1037 O
be 66 68 1038 1040 O
refractory 69 79 1041 1051 O
to 80 82 1052 1054 O
Carfilzomib 83 94 1055 1066 B-treatment
( 95 96 1067 1068 O
refractory 96 106 1068 1078 O
defined 107 114 1079 1086 O
as 115 117 1087 1089 O
having 118 124 1090 1096 O
evidence 125 133 1097 1105 O
of 134 136 1106 1108 O
disease 137 144 1109 1116 O
progression 145 156 1117 1128 O
while 157 162 1129 1134 O
receiving 163 172 1135 1144 O
Carfilzomib 173 184 1145 1156 O
or 185 187 1157 1159 O
within 188 194 1160 1166 O
60 195 197 1167 1169 B-upper_bound
days 198 202 1170 1174 I-upper_bound
of 203 205 1175 1177 O
stopping 206 214 1178 1186 O
Carfilzomib 215 226 1187 1198 B-treatment
therapy 227 234 1199 1206 I-treatment
) 234 235 1206 1207 O

Karnofsky 0 9 1208 1217 B-clinical_variable
≥ 10 11 1218 1219 O
60 12 14 1220 1222 B-lower_bound
% 14 15 1222 1223 I-lower_bound
performance 16 27 1224 1235 B-clinical_variable
status 28 34 1236 1242 I-clinical_variable

Known 0 5 1243 1248 O
HIV 6 9 1249 1252 B-chronic_disease
seropositivity 10 24 1253 1267 O

LVEF 0 4 1268 1272 B-clinical_variable
≥40 5 8 1273 1276 O
% 8 9 1276 1277 I-lower_bound
( 10 11 1278 1279 O
By 11 13 1279 1281 O
echocardiogram 14 28 1282 1296 B-treatment
or 29 31 1297 1299 O
MUGA 32 36 1300 1304 B-treatment
testing 37 44 1305 1312 I-treatment
) 44 45 1312 1313 O

Males 0 5 1314 1319 B-gender

Neuropathy 0 10 1320 1330 B-clinical_variable
≥Grade 11 17 1331 1337 O
3 18 19 1338 1339 I-lower_bound

Patient 0 7 1340 1347 O
has 8 11 1348 1351 O
hypersensitivity 12 28 1352 1368 O
to 29 31 1369 1371 O
any 32 35 1372 1375 O
of 36 38 1376 1378 O
the 39 42 1379 1382 O
components 43 53 1383 1393 O
of 54 56 1394 1396 O
study 57 62 1397 1402 O
therapy 63 70 1403 1410 B-treatment
including 71 80 1411 1420 O
required 81 89 1421 1429 O
prophylactic 90 102 1430 1442 B-allergy_name
medications 103 114 1443 1454 I-allergy_name

Patient 0 7 1455 1462 O
has 8 11 1463 1466 O
received 12 20 1467 1475 O
other 21 26 1476 1481 O
investigational 27 42 1482 1497 B-treatment
drugs 43 48 1498 1503 I-treatment
with 49 53 1504 1508 O
21 54 56 1509 1511 B-upper_bound
days 57 61 1512 1516 I-upper_bound
before 62 68 1517 1523 I-upper_bound
enrollment 69 79 1524 1534 O

Patients 0 8 1535 1543 O
with 9 13 1544 1548 O
evidence 14 22 1549 1557 O
of 23 25 1558 1560 O
significant 26 37 1561 1572 O
mucosal 38 45 1573 1580 B-chronic_disease
or 46 48 1581 1583 I-chronic_disease
internal 49 57 1584 1592 I-chronic_disease
bleeding 58 66 1593 1601 I-chronic_disease

Platelet 0 8 1602 1610 B-clinical_variable
count 9 14 1611 1616 I-clinical_variable
> 15 16 1617 1618 O
50,000 17 23 1619 1625 B-lower_bound
cells 24 29 1626 1631 I-lower_bound
/ 29 30 1631 1632 I-lower_bound
dL 30 32 1632 1634 I-lower_bound
( 33 34 1635 1636 I-lower_bound
50 34 36 1636 1638 I-lower_bound
x 37 38 1639 1640 I-lower_bound
10e9 39 43 1641 1645 I-lower_bound
/ 43 44 1645 1646 I-lower_bound
L 44 45 1646 1647 I-lower_bound
) 45 46 1647 1648 I-lower_bound

Prior 0 5 1649 1654 B-treatment
peripheral 6 16 1655 1665 I-treatment
stem 17 21 1666 1670 I-treatment
cell 22 26 1671 1675 I-treatment
transplant 27 37 1676 1686 I-treatment
within 38 44 1687 1693 O
12 45 47 1694 1696 B-upper_bound
weeks 48 53 1697 1702 I-upper_bound
of 54 56 1703 1705 O
the 57 60 1706 1709 O
first 61 66 1710 1715 O
dose 67 71 1716 1720 O
of 72 74 1721 1723 O
study 75 80 1724 1729 B-treatment
treatment 81 90 1730 1739 I-treatment

Prior 0 5 1740 1745 B-treatment
radiation 6 15 1746 1755 I-treatment
therapy 16 23 1756 1763 I-treatment
or 24 26 1764 1766 O
chemotherapy 27 39 1767 1779 B-treatment
within 40 46 1780 1786 O
2 47 48 1787 1788 B-upper_bound
weeks 49 54 1789 1794 I-upper_bound
or 55 57 1795 1797 O
major 58 63 1798 1803 B-treatment
surgical 64 72 1804 1812 I-treatment
procedure 73 82 1813 1822 I-treatment
within 83 89 1823 1829 O
4 90 91 1830 1831 B-upper_bound
weeks 92 97 1832 1837 I-upper_bound
of 98 100 1838 1840 O
the 101 104 1841 1844 O
first 105 110 1845 1850 O
dose 111 115 1851 1855 O
of 116 118 1856 1858 O
study 119 124 1859 1864 B-treatment
treatment 125 134 1865 1874 I-treatment

Quantitative 0 12 1875 1887 B-clinical_variable
immunoglobulin 13 27 1888 1902 I-clinical_variable
> 28 29 1903 1904 O
500mg 30 35 1905 1910 B-lower_bound
/ 35 36 1910 1911 I-lower_bound
dL 36 38 1911 1913 I-lower_bound
, 38 39 1913 1914 O
only 40 44 1915 1919 O
for 45 48 1920 1923 O
IgA 49 52 1924 1927 B-chronic_disease
and 53 56 1928 1931 O
IgD 57 60 1932 1935 B-chronic_disease
myeloma 61 68 1936 1943 I-chronic_disease
when 69 73 1944 1948 O
the 74 77 1949 1952 O
protein 78 85 1953 1960 O
electrophoresis 86 101 1961 1976 O
under 102 107 1977 1982 O
- 107 108 1982 1983 O
represents 108 118 1983 1993 O
disease 119 126 1994 2001 O
burden 127 133 2002 2008 O

Serious 0 7 2009 2016 O
psychiatric 8 19 2017 2028 B-chronic_disease
illness 20 27 2029 2036 I-chronic_disease

Serum 0 5 2037 2042 O
FLC 6 9 2043 2046 O
assay 10 15 2047 2052 O
: 15 16 2052 2053 O
Involved 17 25 2054 2062 O
FLC 26 29 2063 2066 B-clinical_variable
level 30 35 2067 2072 I-clinical_variable
≥10 36 39 2073 2076 O
mg 40 42 2077 2079 I-lower_bound
/ 42 43 2079 2080 I-lower_bound
dl 43 45 2080 2082 I-lower_bound
( 46 47 2083 2084 O
≥100 47 51 2084 2088 O
mg 52 54 2089 2091 I-lower_bound
/ 54 55 2091 2092 I-lower_bound
l 55 56 2092 2093 I-lower_bound
) 56 57 2093 2094 O

Serum 0 5 2095 2100 B-clinical_variable
M 6 7 2101 2102 I-clinical_variable
- 7 8 2102 2103 I-clinical_variable
protein 8 15 2103 2110 I-clinical_variable
≥0.5 16 20 2111 2115 O
g 21 22 2116 2117 I-lower_bound
/ 22 23 2117 2118 I-lower_bound
dl 23 25 2118 2120 I-lower_bound
( 26 27 2121 2122 O
≥5 27 29 2122 2124 O
g 30 31 2125 2126 I-lower_bound
/ 31 32 2126 2127 I-lower_bound
l 32 33 2127 2128 I-lower_bound
) 33 34 2128 2129 O

Serum 0 5 2130 2135 B-clinical_variable
SGOT 6 10 2136 2140 I-clinical_variable
/ 10 11 2140 2141 I-clinical_variable
AST 11 14 2141 2144 I-clinical_variable
or 15 17 2145 2147 O
SGPT 18 22 2148 2152 B-clinical_variable
/ 22 23 2152 2153 I-clinical_variable
ALT 23 26 2153 2156 I-clinical_variable
< 27 28 2157 2158 O
2.5 29 32 2159 2162 B-upper_bound
x 33 34 2163 2164 I-upper_bound
upper 35 40 2165 2170 I-upper_bound
limit 41 46 2171 2176 I-upper_bound
of 47 49 2177 2179 I-upper_bound
normal 50 56 2180 2186 I-upper_bound
( 57 58 2187 2188 I-upper_bound
ULN 58 61 2188 2191 I-upper_bound
) 61 62 2191 2192 I-upper_bound

Serum 0 5 2193 2198 B-clinical_variable
calcium 6 13 2199 2206 I-clinical_variable
( 14 15 2207 2208 O
corrected 15 24 2208 2217 O
for 25 28 2218 2221 O
albumin 29 36 2222 2229 O
) 36 37 2229 2230 O
level 38 43 2231 2236 O
at 44 46 2237 2239 O
or 47 49 2240 2242 O
below 50 55 2243 2248 O
the 56 59 2249 2252 O
ULN 60 63 2253 2256 O
range 64 69 2257 2262 O
( 70 71 2263 2264 O
treatment 71 80 2264 2273 B-treatment
of 81 83 2274 2276 O
hypercalcemia 84 97 2277 2290 B-chronic_disease
is 98 100 2291 2293 O
allowed 101 108 2294 2301 O
and 109 112 2302 2305 O
subject 113 120 2306 2313 O
may 121 124 2314 2317 O
enroll 125 131 2318 2324 O
if 132 134 2325 2327 O
hypercalcemia 135 148 2328 2341 O
returns 149 156 2342 2349 O
to 157 159 2350 2352 O
normal 160 166 2353 2359 O
with 167 171 2360 2364 O
standard 172 180 2365 2373 B-treatment
treatment 181 190 2374 2383 I-treatment
) 190 191 2383 2384 O
prior 192 197 2385 2390 O
to 198 200 2391 2393 O
study 201 206 2394 2399 O
therapy 207 214 2400 2407 B-treatment
initiation 215 225 2408 2418 O

Subject 0 7 2419 2426 O
has 8 11 2427 2430 O
an 12 14 2431 2433 O
ECOG 15 19 2434 2438 B-clinical_variable
≤ 20 21 2439 2440 O
2 22 23 2441 2442 B-upper_bound
performance 24 35 2443 2454 B-clinical_variable
status 36 42 2455 2461 I-clinical_variable

The 0 3 2462 2465 O
following 4 13 2466 2475 O
laboratory 14 24 2476 2486 O
results 25 32 2487 2494 O
must 33 37 2495 2499 O
be 38 40 2500 2502 O
met 41 44 2503 2506 O
within 45 51 2507 2513 O
7 52 53 2514 2515 B-upper_bound
days 54 58 2516 2520 I-upper_bound
of 59 61 2521 2523 O
study 62 67 2524 2529 O
drug 68 72 2530 2534 O
( 73 74 2535 2536 O
treatment 74 83 2536 2545 B-treatment
) 83 84 2545 2546 O
administration 85 99 2547 2561 O

Total 0 5 2562 2567 B-clinical_variable
bilirubin 6 15 2568 2577 I-clinical_variable
≤ 16 17 2578 2579 O
1.5 18 21 2580 2583 B-upper_bound
x 22 23 2584 2585 I-upper_bound
ULN 24 27 2586 2589 I-upper_bound

Urine 0 5 2590 2595 B-clinical_variable
M 6 7 2596 2597 I-clinical_variable
- 7 8 2597 2598 I-clinical_variable
protein 8 15 2598 2605 I-clinical_variable
≥200 16 20 2606 2610 O
mg/24 21 26 2611 2616 I-lower_bound
h 27 28 2617 2618 I-lower_bound

abnormal 0 8 2619 2627 B-clinical_variable
serum 9 14 2628 2633 I-clinical_variable
free 15 19 2634 2638 I-clinical_variable
light 20 25 2639 2644 I-clinical_variable
chain 26 31 2645 2650 I-clinical_variable
ratio 32 37 2651 2656 I-clinical_variable
( 38 39 2657 2658 O
< 39 40 2658 2659 O
0.26 40 44 2659 2663 B-upper_bound
or 45 47 2664 2666 O
> 48 49 2667 2668 O
1.65 49 53 2668 2672 B-lower_bound
) 53 54 2672 2673 O

active 0 6 2674 2680 O
hepatitis 7 16 2681 2690 B-chronic_disease
B 17 18 2691 2692 I-chronic_disease
or 19 21 2693 2695 I-chronic_disease
C 22 23 2696 2697 I-chronic_disease
viral 24 29 2698 2703 I-chronic_disease
infection 30 39 2704 2713 I-chronic_disease

active 0 6 2714 2720 O
peptic 7 13 2721 2727 B-chronic_disease
ulcer 14 19 2728 2733 I-chronic_disease

age 0 3 2734 2737 B-age
18 4 6 2738 2740 B-lower_bound
years 7 12 2741 2746 I-lower_bound
or 13 15 2747 2749 O
older 16 21 2750 2755 O

atients 0 7 2756 2763 O
may 8 11 2764 2767 O
have 12 16 2768 2772 O
received 17 25 2773 2781 O
prior 26 31 2782 2787 B-treatment
Carfilzomib 32 43 2788 2799 I-treatment
( 44 45 2800 2801 O
sensitive 45 54 2801 2810 O
, 54 55 2810 2811 O
relapsed 56 64 2812 2820 O
and 65 68 2821 2824 O
refractory 69 79 2825 2835 O
all 80 83 2836 2839 O
eligible 84 92 2840 2848 O
) 92 93 2848 2849 O
but 94 97 2850 2853 O
must 98 102 2854 2858 O
be 103 105 2859 2861 O
> 106 107 2862 2863 O
4 108 109 2864 2865 B-lower_bound
weeks 110 115 2866 2871 I-lower_bound
from 116 120 2872 2876 O
last 121 125 2877 2881 O
dosing 126 132 2882 2888 O
of 133 135 2889 2891 O
Carfilzomib 136 147 2892 2903 O

bowel 0 5 2904 2909 B-treatment
resection 6 15 2910 2919 I-treatment
affecting 16 25 2920 2929 O
absorption 26 36 2930 2940 O

complete 0 8 2941 2949 B-treatment
resection 9 18 2950 2959 I-treatment
of 19 21 2960 2962 O
basal 22 27 2963 2968 B-cancer
cell 28 32 2969 2973 I-cancer
carcinoma 33 42 2974 2983 I-cancer
or 43 45 2984 2986 O
squamous 46 54 2987 2995 B-cancer
cell 55 59 2996 3000 I-cancer
carcinoma 60 69 3001 3010 I-cancer
of 70 72 3011 3013 I-cancer
the 73 76 3014 3017 I-cancer
skin 77 81 3018 3022 I-cancer
, 81 82 3022 3023 O
an 83 85 3024 3026 O
in 86 88 3027 3029 B-cancer
situ 89 93 3030 3034 I-cancer
malignancy 94 104 3035 3045 I-cancer
, 104 105 3045 3046 O
low 106 109 3047 3050 O
- 109 110 3050 3051 O
risk 110 114 3051 3055 O
prostate 115 123 3056 3064 B-cancer
cancer 124 130 3065 3071 I-cancer
after 131 136 3072 3077 O
curative 137 145 3078 3086 B-treatment
therapy 146 153 3087 3094 I-treatment
or 154 156 3095 3097 O
complete 157 165 3098 3106 O
resection 166 175 3107 3116 O
of 176 178 3117 3119 O
other 179 184 3120 3125 O
advanced 185 193 3126 3134 O
malignancy 194 204 3135 3145 O
with 205 209 3146 3150 O
the 210 213 3151 3154 O
expectation 214 225 3155 3166 O
that 226 230 3167 3171 O
the 231 234 3172 3175 O
patient 235 242 3176 3183 O
has 243 246 3184 3187 O
received 247 255 3188 3196 O
curative 256 264 3197 3205 O
therapy 265 272 3206 3213 O

females 0 7 3214 3221 B-gender

has 0 3 3222 3225 O
not 4 7 3226 3229 O
been 8 12 3230 3234 O
naturally 13 22 3235 3244 O
postmenopausal 23 37 3245 3259 O
for 38 41 3260 3263 O
at 42 44 3264 3266 O
least 45 50 3267 3272 O
24 51 53 3273 3275 B-lower_bound
consecutive 54 65 3276 3287 O
months 66 72 3288 3294 O
may 73 76 3295 3298 O
be 77 79 3299 3301 O
included 80 88 3302 3310 O
if 89 91 3311 3313 O
the 92 95 3314 3317 O
patient 96 103 3318 3325 O
is 104 106 3326 3328 O
not 107 110 3329 3332 B-pregnancy
pregnant 111 119 3333 3341 I-pregnancy
by 120 122 3342 3344 O
a 123 124 3345 3346 O
negative 125 133 3347 3355 O
serum 134 139 3356 3361 B-clinical_variable
β 140 141 3362 3363 I-clinical_variable
- 141 142 3363 3364 I-clinical_variable
human 142 147 3364 3369 I-clinical_variable
chorionic 148 157 3370 3379 I-clinical_variable
gonadotropin 158 170 3380 3392 I-clinical_variable
( 171 172 3393 3394 I-clinical_variable
β 172 173 3394 3395 I-clinical_variable
- 173 174 3395 3396 I-clinical_variable
hCG 174 177 3396 3399 I-clinical_variable
) 177 178 3399 3400 I-clinical_variable
pregnancy 179 188 3401 3410 B-pregnancy
test 189 193 3411 3415 O
result 194 200 3416 3422 O
obtained 201 209 3423 3431 O
during 210 216 3432 3438 O
screening 217 226 3439 3448 O

has 0 3 3449 3452 O
not 4 7 3453 3456 O
undergone 8 17 3457 3466 O
a 18 19 3467 3468 O
hysterectomy 20 32 3469 3481 B-treatment
or 33 35 3482 3484 O
bilateral 36 45 3485 3494 B-treatment
oophorectomy 46 58 3495 3507 I-treatment

inability 0 9 3508 3517 O
to 10 12 3518 3520 O
take 13 17 3521 3525 O
oral 18 22 3526 3530 O
medication 23 33 3531 3541 B-treatment

must 0 4 3542 3546 O
be 5 7 3547 3549 O
> 8 9 3550 3551 O
than 10 14 3552 3556 O
four 15 19 3557 3561 O
half 20 24 3562 3566 O
- 24 25 3566 3567 O
lives 25 30 3567 3572 O
of 31 33 3573 3575 O
the 34 37 3576 3579 O
experimental 38 50 3580 3592 B-treatment
agent 51 56 3593 3598 I-treatment

painful 0 7 3599 3606 B-clinical_variable
neuropathy 8 18 3607 3617 I-clinical_variable
≥Grade 19 25 3618 3624 O
2 26 27 3625 3626 I-lower_bound

prior 0 5 3627 3632 B-treatment
surgical 6 14 3633 3641 I-treatment
procedures 15 25 3642 3652 O

requirement 0 11 3653 3664 O
for 12 15 3665 3668 O
intravenous 16 27 3669 3680 B-treatment
( 28 29 3681 3682 I-treatment
IV 29 31 3682 3684 I-treatment
) 31 32 3684 3685 I-treatment
alimentation 33 45 3686 3698 O

